VHCP Management II as of March 31, 2019
Portfolio Holdings for VHCP Management II
VHCP Management II holds 21 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 17.4 | $59M | 504k | 117.70 | |
| Biohaven Pharmaceutical Holding | 17.1 | $59M | 1.1M | 51.47 | |
| Tricida | 10.9 | $37M | 963k | 38.62 | |
| Shockwave Med (SWAV) | 8.8 | $30M | 901k | 33.47 | |
| Obseva Sa | 8.4 | $29M | 2.3M | 12.79 | |
| BioCryst Pharmaceuticals (BCRX) | 7.7 | $26M | 3.2M | 8.14 | |
| Zogenix | 5.8 | $20M | 362k | 55.01 | |
| Kalvista Pharmaceuticals (KALV) | 4.8 | $16M | 574k | 28.62 | |
| Ra Pharmaceuticals | 4.2 | $14M | 633k | 22.40 | |
| Kiniksa Pharmaceuticals (KNSA) | 3.4 | $12M | 639k | 18.06 | |
| Constellation Pharmceticls I | 2.9 | $9.8M | 727k | 13.55 | |
| Axsome Therapeutics (AXSM) | 2.4 | $8.1M | 572k | 14.23 | |
| Spero Therapeutics (SPRO) | 1.8 | $6.1M | 474k | 12.81 | |
| Protagonist Therapeutics (PTGX) | 1.0 | $3.4M | 271k | 12.57 | |
| Marinus Pharmaceuticals | 0.9 | $3.1M | 744k | 4.18 | |
| Bellerophon Therapeutics | 0.8 | $2.7M | 4.1M | 0.65 | |
| La Jolla Pharmaceuticl Com Par | 0.7 | $2.4M | 371k | 6.43 | |
| Kadmon Hldgs | 0.6 | $2.2M | 820k | 2.64 | |
| Gemphire Therapeutics | 0.2 | $591k | 514k | 1.15 | |
| Proteostasis Therapeutics In | 0.2 | $538k | 427k | 1.26 | |
| Orchard Therapeutics Plc ads | 0.1 | $221k | 12k | 17.85 |
